// App-Quantinova.ai

BSH2020‐PO‐014 : Analysis of treatment patterns and outcomes for patients with therapy‐related acute myeloid leukaemia and acute myeloid leukaemia with myelodysplasia‐related changes diagnosed in England between 2011–2016 using hospital episode statistics®

Researchers

Presenter

  • A. Legg

Principal Investigators

  • T. Ellison

  • M. O'Connell

  • M. Evans

Medical Centers

  • Jazz Pharmaceuticals, Oxford

  • Harvey Walsh, Runcorn, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Myelodysplastic Syndrome

  • Solid malignancies

Biomarkers

  • Nucleophosmin 1

  • CCAAT enhancer binding protein alpha

  • Hematocrit

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Vidaza

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved